4-amino-5-cyanopyrimidine derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 16, 2010
Issued Date -
N/A
app pub date -
Apr 28, 2005
filing date -
Apr 30, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
are defined herein, or pharmaceutically acceptable salts thereof, having a safe and potent adenosine A2a receptor agonistic activity; and also provides an adenosine A2a receptor agonist, an intraocular pressure reducing agent, or a medicine for treating glaucoma, etc., which comprises the compound as an active ingredient.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully